Scripps Health
Avatar

2021 Update on HF Pharmacological Management: HF & Cardiac Amyloidosis Therapeutic Approaches and Clinical Trials Overview

By Scripps Health FEATURING Thomas Heywood
By Scripps Health FEATURING Thomas Heywood
568 views
August 25, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
15:38
CCM® Therapy

THT 2024: CCM® Therapy - Don’t Wait!

Feat. R. Kahwash
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
18:34
Houston Methodist DeBakey Heart and Vascular Center

ECG Interpretation: Everything You Need to Know to Understand and In…

Feat. A. Dave
16:45
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

Feat. S. Lentzsch
10:09
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
09:47
CCM® Therapy

THT 2024: Heart Failure Management Today – GDMT, CRT, and CCM® Thera…

Feat. J. Butler
12:28
CCM® Therapy

THT 2024: Update on the Integra-D Trial - CCM® Therapy

Feat. N. Varma
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic